BiBB’s CEO to BioStock: “Zagreb confirms good samples and short learning curve”
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

BiBB’s CEO to BioStock: “Zagreb confirms good samples and short learning curve”

The clinical introduction is in full swing for BiBBInstruments. The company’s first electric-driven biopsy instrument, EndoDrill GI, continues to impress with high-quality tissue samples, most recently at an introduction of EndoDrill GI at the University Hospital in Zagreb. Meanwhile, the European Patent Office announced the intention to grant the patent application for the EndoDrill technology. BioStock spoke to BiBB’s CEO Fredrik Lindblad to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/09/bibbs-ceo-zagreb-confirms-good-samples-and-short-learning-curve/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Nyheter om BiBBInstruments

Läses av andra just nu

Om aktien BiBBInstruments

Senaste nytt